NOV 10 2023 News Releases Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy (Link to Recor website)
NOV 08 2023 News Releases Otsuka Medical Devices and Recor Medical Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
OCT 26 2023 News Releases Recor Medical Announces Positive Results from Six-Month Pooled Analysis of Data from the RADIANCE Global Clinical Trial Program at TCT 2023 (Link to Recor website)
OCT 20 2023 News Releases Recor Medical to Present Latest Clinical Data on Paradise™ Ultrasound Renal Denervation at TCT Annual Meeting (Link to Recor website)
SEP 20 2023 News Releases Recor Medical Unveils Refreshed Brand to Showcase Company's Vision for the Future (Link to Recor website)
AUG 23 2023 News Releases Otsuka Medical Devices and Recor Medical Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension
JUL 17 2023 News Releases ReCor Responds to European Society of Hypertension's (ESH) Updated Guidelines for Management of Arterial Hypertension (Link to ReCor website)
MAR 07 2023 News Releases Otsuka Medical Devices appoints Board Members and Audit & Supervisory Board Members
FEB 28 2023 News Releases Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension (Link to ReCor website)
FEB 22 2023 Information Donations to Support Relief Efforts Following Earthquakes in Turkey and Syria (Link to Otsuka Pharmaceutical website)